+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Therapeutic and pharmacological monitoring in individualization of primidone monotherapy of epileptic patients



Therapeutic and pharmacological monitoring in individualization of primidone monotherapy of epileptic patients



Zhurnal Nevropatologii i Psikhiatrii Imeni S S Korsakova 91(6): 34-38



The treatment with primidone alone of 53 epileptic patients with generalized tonicoclonic seizures, partial attacks with elementary symptomatology, and partial fits with complex symptomatology removed them completely in 75, 64.2, and 36.9% of the patients, respectively. The number of attacks was decreased as a result by 50% and over in 90, 78.6, and 73.7% of the patients, respectively. The attainment of such high efficacy of the monotherapy (called by the author intensive in contrast to routine or inadequate therapy carried out, as a rule, in standard doses) appeared possible only under the conditions of individualization of the drug doses which ranged within 250-2500 mg/day. The concentration of phenobarbital, the main end metabolite of primidone, in the blood serum of patients, in whom the attacks were completely arrested and who developed no clinical side effects with no toxic action on the internal organs, ranged from 14 to 59.1 mg/l. In partial fits with complex symptomatology, primidone appeared least effective for those types of fits in the treatment of which it was viewed as most adequate.

Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 007946427

Download citation: RISBibTeXText


Related references

Therapeutic and pharmacological monitoring of individual monotherapy of epilepsy with hexamidine. Zhurnal Nevropatologii i Psikhiatrii Imeni S.S. Korsakova 91(6): 34-38, 1991

The influence of plasma level monitoring of anti epileptic drugs on therapeutic outcome in epileptic out patients part 2 results. Naunyn Schmiedeberg'S Archives Of Pharmacologyuppl: R64, 1978

The influence of plasma level monitoring of anti epileptic drugs on therapeutic outcome in epileptic out patients part 1 study design. Naunyn Schmiedeberg'S Archives Of Pharmacologyuppl: R64, 1978

Therapeutic serum concentrations of primidone and its metabolites, phenobarbital and phenylethylmalonamide in epileptic dogs. Journal of the American Veterinary Medical Association 182(10): 1091-1094, 1983

Therapeutic drug monitoring for dose individualization of Cisplatin in testicular cancer patients based upon total platinum measurement in plasma. Therapeutic Drug Monitoring 28(4): 532-539, 2006

Bioavailability of primidone in epileptic patients. International Journal of Clinical Pharmacology Therapy and Toxicology 9(2): 132-137, 1974

Therapeutic drug monitoring of primidone. Nihon Rinsho. Japanese Journal of Clinical Medicine 48 Suppl: 1140-1142, 1990

Therapeutic monitoring in the individualized monotherapy with benzonal of epilepsy patients. Farmakologiia i Toksikologiia 54(4): 55-56, 1991

Therapeutic drug monitoring of primidone and phenobarbital. Therapie 67(4): 381-390, 2016

A study on the effectiveness of carbamazepine vs primidone in epileptic out patients. Electroencephalography & Clinical Neurophysiology: 295, 1975

Hematic radio-immunologic monitoring of clonazepam: clinical-pharmacological evaluations in a group of epileptic patients. Rivista di Neurologia 49(3): 259-267, 1979

Intoxication with primidone: continuous monitoring of serum primidone and its metabolites during forced diuresis. Neuropadiatrie 8(2): 190-195, 1977

Brain concentrations of phenytoin, phenobarbitone and primidone in epileptic patients. European Journal of Clinical Pharmacology 9(1): 73-78, 1975

The role of therapeutic drug monitoring in the care of epileptic patients. South African Medical Journal 62(15): 512-515, 1982

Role of therapeutic drug monitoring in the care of epileptic patients. South African Medical Journal 62(15): 512-514, 515, 1982